Tuesday, 23 June 2009



Author: Burrill & Company

Contains analysis and perspectives on the performance of the biotechnology industry in 2008, and presents financial projections for 2009 and beyond. Market segments covered include: healthcare, personalizing medicine, emerging technologies, "bio green tech" and wellness.

No comments: